Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MDCX is expected to report earnings to fall 48.84% to -21 cents per share on November 21
Q3'25
Est.
$-0.22
Q2'25
Missed
by $0.18
The last earnings report on August 12 showed earnings per share of -43 cents, missing the estimate of -25 cents. With 197.91K shares outstanding, the current market capitalization sits at 35.20M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MDCX showed earnings on August 12, 2025. You can read more about the earnings report here.